• RIPostC, Ketone Bodies, and Ferroptosis in Stroke

  2026-09-18

  A 2024 ACS Chemical Neuroscience study identifies ketone body production and ferroptosis suppression as a mechanistic link between remote ischemic postconditioning and neuroprotection after ischemic stroke. Its rat and HT22-cell experiments connect improved energy metabolism with GPX4 preservation, ACSL4 reduction, iron control, and mitochondrial protection, providing a framework for testing 3-hydroxybutyrate and related metabolic interventions.

• IL-2, Human Recombinant in Neuronal Granule Studies

  2026-09-18

  Explore how IL-2, human recombinant can serve as a defined signaling perturbation in studies of neuronal granules, FUS phase separation, and SMN function. This article separates established Cell Reports mechanisms from testable cytokine-based experimental applications.

• LG 101506: RXR Signaling to Immune Translation

  2026-09-17

  A translational framework for using LG 101506 to interrogate RXR biology, connect nuclear receptor signaling with immune-checkpoint phenotypes, and test—not assume—relationships between RXR activity and the RBMS1–B4GALT1–PD-L1 axis in triple-negative breast cancer.

• Metabolic Sensitization of Ferroptosis and Cuproptosis

  2026-09-17

  Zhang and colleagues developed a Cu–tannic acid/liposome nanosystem carrying STF-31 to inhibit glycolysis and compensatory NAD+ metabolism, thereby increasing tumor-cell susceptibility to ferroptosis and cuproptosis. The study connects metabolic depletion with copper retention, redox failure, immunogenic cell death, and tumor immune remodeling, offering a mechanistic framework for combination nanomedicine design.

• Rocilinostat (ACY-1215) Experimental Workflow

  2026-09-16

  Rocilinostat (ACY-1215) enables selective HDAC6 target-engagement studies, multiple myeloma viability testing, and carefully controlled proteasome-inhibitor combination experiments. This workflow also shows how α-tubulin acetylation can support hypothesis-generating cilia studies without confusing cancer evidence with developmental biology evidence.

• MG-132: From Proteasome Stress to p53 Strategy

  2026-09-16

  A translational guide to using MG-132 and Z-LLL-al to connect proteasome perturbation with apoptosis, cell-cycle control, oxidative stress, and the emerging XIAP–p53 axis.

• Angiotensin III: A Receptor-Resolved RAAS Tool

  2026-09-15

  Angiotensin III is a powerful cardiovascular research peptide for dissecting receptor-selective RAAS signaling, aldosterone release, and pressor responses. This article adds an assay-centered framework for interpreting emerging spike–receptor binding data without overstating translational evidence.

• CX-4945: CK2 Inhibition Workflow for Lung Cancer

  2026-09-15

  CX-4945 (Silmitasertib) enables a mechanism-led workflow that connects CK2 activity with signaling, ECE-1c stability, apoptosis, cell-cycle behavior, and cisplatin resistance. This practical guide translates lung cancer findings into dosing, controls, readouts, and troubleshooting decisions for reproducible cancer biology experiments.

• Nanoparticle Uptake in Human Corneal Epithelial Cells

  2026-09-14

  Azadi and David systematically examined how PLGA nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells. Their in vitro model linked particle properties to energy-dependent internalization, identifying macropinocytosis and caveolae-mediated endocytosis as dominant pathways while clarifying the limited role of phagocytosis.

• LG 101506: RXR Modulator Research Guide

  2026-09-14

  LG 101506 is a synthetic RXR modulator for research into nuclear receptor signaling, retinoid biology, and metabolism regulation. Its reported molecular identity, formulation data, storage guidance, and research-use boundaries are distinct from the TNBC checkpoint findings used here as a mechanistic context.

• Annexin V-Cy5 Apoptosis Kit in Microglia

  2026-09-13

  Use the Annexin V-Cy5 Apoptosis Kit to separate phosphatidylserine exposure from lysosomal stress in microglia and zebrafish neurotoxicology models. Its rapid Cy5 readout supports complementary microscopy and flow cytometry workflows, helping researchers determine whether a treatment causes cell death or impaired intracellular processing.

• CD38 CAR Binders: Structure-Guided Affinity Tuning

  2026-09-12

  This iScience study combines structural biology, alanine scanning, enzymatic assays, and CAR-T testing to explain how the CD38 binders RP02 and 028 recognize the antigen differently. Its affinity-attenuated 028R103G variant reduced CAR-T fratricide while retaining cytotoxicity against CD38-positive tumor cells, providing a framework for balancing antigen engagement, catalytic inhibition, and cellular selectivity.

• TLS, STING, and B-Cell Activation in ESCC

  2026-09-11

  A 2025 study links tertiary lymphoid structures with favorable survival in treatment-naïve esophageal squamous cell carcinoma and identifies IRF4-positive tumor-infiltrating B cells as a central immune population. Its mechanistic work proposes that CD40 and STING compete for TRAF2, reshaping non-canonical NF-κB signaling and promoting IRF4-mediated B-cell activation.

• Ceruletide Workflows for Pancreatic Fibrosis

  2026-09-11

  Ceruletide provides a controllable CCK-receptor stimulus for linking pancreatic injury, stellate-cell activation, and fibrosis biology. This guide translates the ORM2–ZG16 findings into practical sample-handling, assay-design, gastrointestinal physiology, and troubleshooting workflows.

• Disodium bicinchoninate in Cardiac Assays

  2026-09-10

  Disodium bicinchoninate provides an aqueous route for chelation-based assay development, protein normalization, and matrix testing in cell-based cardiac research. This practical workflow connects the reagent’s formulation advantages with high-glucose cardiomyocyte and BMSC experiments while clearly separating reference-study findings from optimization recommendations.

8050 records 1/537 page Next 12345 下5页 Last page